Advertisement
Advertisement

NRSN

NRSN logo

NeuroSense Therapeutics Ltd. Ordinary Shares

0.88
USD
Sponsored
0.00
+0.34%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

0.88

0.00
+0.23%

NeuroSense Therapeutics Ltd. Ordinary Shares Profile

About

NeuroSense Therapeutics Ltd. is a clinical-stage biotechnology company. It focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, such as ALS, Alzheimer's and Parkinson's disease. NeuroSense Therapeutics Ltd. is based in CAMBRIDGE, Mass.

Info & Links

CEO

Alon Ben-Noon

Headquarters

11 HAMENOFIM ST.,BUILDING B
HERZLIYA, L3 4672562, ISRAEL

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.neurosense-tx.com

Auditor

Somekh Chaikin

Share holders

--

Employees

18

NeuroSense Therapeutics Ltd. Ordinary Shares Statistics

Valuation Measures

Market Capitalization2

31.84M

Enterprise Value

31.75M

Enterprise Value/EBITDA(ttm)

-10.60

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

77.89%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-2.99M

Net Income Available to Common(ttm)

-5.40M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

1.70

52-Week Change

-16.18%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

32.56M

Dividend Yield

0.00%

Float4

23.64M

% Held by Insiders

27.40%

% Held by Institutions

1.04%

Balance Sheet

Total Cash(mrq)

213.00K

Total Cash Per Share(mrq)

0.01

Total Debt(mrq)

72.00K

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

0.31%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement